NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/23/2025
Back to search
Official data from USPTO
PHARMAVENTURES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMAVENTURES
ST13
US500000086455967Class
35, 36, 42, 45
Filing
86455967
Registration
4772557
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
10/14/2025
Trademark type
Word
Nice classes
35, 36, 42, 45
Filing date
11/17/2014
Registration date
07/14/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/23/2025
Last transaction
10/14/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/30/1997
First use in commerce
11/30/1997
Drawing code
4
Owner type
16
Owner location
Oxford, GB
Examiner
BRODY,DANIEL S
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Pharmaventures Limited
Representatives
Laurence P. Colton SMITH TEMPEL BLAHA LLC
Technical classification
Nice Classes
Class 35Class 36Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Advertisingmarketing and promotion services in the field of conceptsproductssupplements and preparations related to medicationdietetic products medicated and non-medicated additives for foodstuffs and beveragesdiagnostic products; Business acquisition and merger consultation; Business advisory services in the field of pharmaceuticalhealthcare researchmedicated and non-medicated food and beverage and dietary supplements industriesproduct licensing and transfer services for other of pharmaceutical drugsmedical devicesdrug delivery devicesdiagnostics and platform technologies that accelerate drug discovery and development; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business consulting services in the field of pharmaceuticalhealthcare researchmedicated and non-medicated food and beverage and dietary supplements industriesproduct licensing and transfer services for other of pharmaceutical drugsmedical devicesdrug delivery devicesdiagnostics and platform technologies that accelerate drug discovery and development; Business research services in the field of healthcare research and development of pharmaceuticals and dietary preparationssubstancessupplements performed for others; business consulting services in the field of assisting others in obtaining clinical trial and research services in the fields of pharmaceuticals and biotechnology; Business strategy development services; Consulting services in the field of managing intellectual properties; Consulting services in the field of medical product approval for commercial purposes; Expert evaluations and reports relating to business matters; Market research services
Class 36
Intellectual property valuation services
Class 42
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields
Class 45
Consulting in the field of intellectual property licensing
Publications
History of USPTO decisions and trademark events.
26 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/23/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/23/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/22/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
05/30/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/14/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/01/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/01/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/01/2021
E815
TEAS SECTION 8 & 15 RECEIVED
06/18/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/14/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/14/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/28/2015
PUBO
PUBLISHED FOR OPPOSITION
04/28/2015
DOCK
ASSIGNED TO EXAMINER
04/20/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/08/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/21/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/21/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
03/17/2015
ALIE
ASSIGNED TO LIE
03/17/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/17/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
03/17/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/17/2015
DOCK
ASSIGNED TO EXAMINER
03/07/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/22/2014
NWAP
NEW APPLICATION ENTERED
11/20/2014
Continuous trademark protection
Get notified about every new filing that threatens PHARMAVENTURES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.